Recent Advances in Detection, and Management of Hyperlipidemias
Prof. Undurti N. Das E-Mail
CEO and CSO, UND Life Sciences, Battle Ground, WA 98604, USA
Research Keywords: lipids; immunology; rheumatology; endocrinology; diabetes mellitus; inflammation; sepsis; lipidology; clinical immunology
Hyper lipids is common in those with obesity, insulin resistance, diabetes mellitus, coronary heart disease and metabolic syndrome. Hyperlipidemia is also associated with non- alcoholic fatty liver disease and non- alcoholic strati hepatitis. In some instances it may occur as a stand-alone abnormality. Since hyperlipidemias may predispose to the development of coronary heart disease and other diseases, it need to be prevented or suppressed at an early date. In majority of the instances, hyperlipidemias are due to high intake of high fat diet, calorie/rich diet though genetic causes also need to be kept in mind. In general, subjects who have hyperlipidemias are less active physically and lead a sedentary life. Thus, hyperlipidemias can also be considered as a disease of altered lifestyle. Hyperlipidemias can be treated with diet control, exercise and specific medicines. In this special issue all aspects of hyperlipidemias will be considered for publication including its associated diseases as outlined above.
We welcome reviews, hypothesis, commentaries, original articles and other types of manuscripts for publication. All submissions will undergo peer-review before acceptance.
I look forward to receive your manuscript for this interesting and timely topic.
Undurti N Das, MD, DSc, FRSC